載入...

Neutralizing antibodies for the treatment of COVID-19

More clinical trial data are needed to determine whether sera from COVID-19-convalescent patients and neutralizing monoclonal antibodies specific to SARS-CoV-2 antigens can prevent COVID-19 or reduce the severity of the disease in high-risk populations.

Na minha lista:
書目詳細資料
發表在:Nat Biomed Eng
Main Authors: Jiang, Shibo, Zhang, Xiujuan, Yang, Yang, Hotez, Peter J., Du, Lanying
格式: Artigo
語言:Inglês
出版: 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7891858/
https://ncbi.nlm.nih.gov/pubmed/33293725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41551-020-00660-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!